A Psychology Today piece argues that standard employee assistance programs don't account for the unique mental health pressures faced by workers like firefighters, farmers, and emergency personnel. The article calls for peer support networks and profession-specific mental health resources instead.
Health & Wellness News
This article highlights how consistent basics — like eating balanced meals, staying hydrated, and leaning on trusted people in your life — can meaningfully reduce stress over time.
Unmanaged stress can quietly chip away at your sleep, energy, focus, and relationships over time. This article offers approachable strategies for supporting your mental wellness without demanding perfection. A useful read if stress has been making even small daily tasks feel like too much.
Despite growing demand, only about 36% of employers cover GLP-1 drugs for weight loss — a figure that has barely budged from last year.
A New York Times opinion piece uses writer Caroline Calloway's personal essay about taking Ozempic — despite not being overweight — as a jumping-off point to examine how GLP-1 drugs are being used beyond their intended medical purpose.
According to a new Gallup poll, 11% of Americans are currently on a GLP-1 medication like Wegovy, with 15% having tried one at some point — a sharp rise from 6% just a year ago. The numbers highlight how quickly these drugs have gone from niche treatments to mainstream weight loss tools.
A new Gallup survey confirms that GLP-1 weight loss drug use has surged to record levels in the U.S., with 11% of Americans currently taking one of these medications. This represents a massive jump over the past two years and reflects growing mainstream acceptance of drugs like Ozempic and Wegovy.
A secret shopper study by Yale University researchers, published in JAMA, found that telehealth platforms are prescribing GLP-1 weight loss drugs with little medical oversight — confirming long-standing concerns from doctors.